https://www.ndtvprofit.com/business/biocon-need-not-be-too-worried-about-us-regulators-observations-say-brokerages?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The observations appear benign with no data integrity issues and mainly pertain to quality and controls.